The potential risk of infections during (prolonged) rituximab therapy in rheumatoid arthritis

Ithamar Heber Brinkman, Mart A F J van de Laar, Tim L. Jansen, E.N. van Roon

    Research output: Contribution to journalArticleAcademicpeer-review

    14 Citations (Scopus)
    Original languageDutch
    Pages (from-to)715-726
    JournalExpert opinion on drug safety
    Volume10
    Issue number5
    DOIs
    Publication statusPublished - 2011

    Keywords

    • METIS-282236

    Cite this